CL43546B - Compuesto derivado de tetrahidroquinolina con actividad moduladora del receptor fsh; composicion farmaceutica que contiene al compuesto; y uso del compuesto en la preparacion de medicamentos para la regulacion de la fertilidad. - Google Patents
Compuesto derivado de tetrahidroquinolina con actividad moduladora del receptor fsh; composicion farmaceutica que contiene al compuesto; y uso del compuesto en la preparacion de medicamentos para la regulacion de la fertilidad.Info
- Publication number
- CL43546B CL43546B CL200302684A CL2003002684A CL43546B CL 43546 B CL43546 B CL 43546B CL 200302684 A CL200302684 A CL 200302684A CL 2003002684 A CL2003002684 A CL 2003002684A CL 43546 B CL43546 B CL 43546B
- Authority
- CL
- Chile
- Prior art keywords
- compound
- tetrahydroquinoline
- fertility
- medicines
- regulation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 3
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 230000035558 fertility Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02102865 | 2002-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL43546B true CL43546B (es) | 2005-04-08 |
Family
ID=38799446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200302684A CL43546B (es) | 2002-12-20 | 2003-12-18 | Compuesto derivado de tetrahidroquinolina con actividad moduladora del receptor fsh; composicion farmaceutica que contiene al compuesto; y uso del compuesto en la preparacion de medicamentos para la regulacion de la fertilidad. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7674909B2 (es) |
| EP (1) | EP1578727B1 (es) |
| JP (1) | JP4545000B2 (es) |
| AR (1) | AR042629A1 (es) |
| AT (1) | ATE392416T1 (es) |
| AU (1) | AU2003303221B2 (es) |
| BR (1) | BR0317514A (es) |
| CA (1) | CA2508923C (es) |
| CL (1) | CL43546B (es) |
| DE (1) | DE60320457T2 (es) |
| DK (1) | DK1578727T3 (es) |
| ES (1) | ES2304544T3 (es) |
| MX (1) | MXPA05006772A (es) |
| NZ (1) | NZ540577A (es) |
| PE (1) | PE20040799A1 (es) |
| PL (1) | PL376997A1 (es) |
| PT (1) | PT1578727E (es) |
| RS (1) | RS51196B (es) |
| RU (1) | RU2328487C2 (es) |
| SI (1) | SI1578727T1 (es) |
| TW (1) | TWI322012B (es) |
| UA (1) | UA80303C2 (es) |
| WO (1) | WO2004056779A2 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20031080A2 (en) * | 2001-07-02 | 2004-04-30 | Akzo Nobel Nv | Tetrahydroquinoline derivatives |
| TWI306855B (en) * | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
| DE10260739B3 (de) | 2002-12-23 | 2004-09-16 | Outokumpu Oy | Verfahren und Anlage zur Herstellung von Metalloxid aus Metallverbindungen |
| US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| UA92007C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| UA92008C2 (en) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| ES2361674T3 (es) * | 2005-05-04 | 2011-06-21 | N.V. Organon | Derivados de dihidropiridina. |
| UA92009C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
| WO2006124523A1 (en) * | 2005-05-12 | 2006-11-23 | Wyeth | Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(fish-r) antagonists |
| AU2006247601A1 (en) | 2005-05-12 | 2006-11-23 | Wyeth | Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists |
| BRPI0611720A2 (pt) | 2005-06-09 | 2016-11-22 | Wyeth Corp | "composto, composição, e, métodos de inibir a fertilidade,de evitar a concepção, e de bloquear o desenvolvimento folicular mediado por fsh em um mamífero" |
| TW200918058A (en) * | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
| US20100061976A1 (en) * | 2008-07-24 | 2010-03-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| RU2720237C2 (ru) | 2013-11-18 | 2020-04-28 | Форма Терапеутикс, Инк. | Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет |
| MX370535B (es) | 2013-11-18 | 2019-12-17 | Forma Therapeutics Inc | Compuestos de tetrahidroquinolina como inhibidores del bromodominio extra terminal y bromo (bet) y el uso de los mismos en el tratamiento de cáncer. |
| WO2019055877A1 (en) | 2017-09-15 | 2019-03-21 | Forma Therapeutics, Inc. | TETRAHYDROIMIDAZO QUINOLINE COMPOSITIONS AS INHIBITORS OF CBP / P300 |
| MX2023013508A (es) | 2018-06-29 | 2023-12-13 | Forma Therapeutics Inc | Inhibicion de la proteina de union a creb (cbp). |
| EP3937940A4 (en) | 2019-03-15 | 2022-12-21 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (creb) |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2686182A (en) * | 1950-12-07 | 1954-08-10 | Basf Ag | O-hydroxy-dihydro-quinoline carboxylic acids |
| EP0303306B1 (en) | 1987-08-08 | 1993-03-10 | Akzo N.V. | Contraceptive implant |
| CZ285937B6 (cs) * | 1992-01-16 | 1999-12-15 | Hoechst Aktiengesellschaft | Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití |
| NZ300739A (en) * | 1994-12-22 | 2000-05-26 | Ligand Pharm Inc | Steroid receptor modulator compounds |
| DE69931975T2 (de) * | 1998-08-07 | 2006-10-05 | Applied Research Systems Ars Holding N.V. | FSH Mimetika zur Behandlung von Infertilität |
| US6200963B1 (en) * | 1999-03-31 | 2001-03-13 | American Home Products Corporation | Aryl sulfonic acids as FSH antagonists |
| HRP20031080A2 (en) * | 2001-07-02 | 2004-04-30 | Akzo Nobel Nv | Tetrahydroquinoline derivatives |
| TWI306855B (en) * | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
-
2003
- 2003-12-15 TW TW092135440A patent/TWI322012B/zh not_active IP Right Cessation
- 2003-12-16 US US10/540,335 patent/US7674909B2/en not_active Expired - Lifetime
- 2003-12-16 AT AT03808299T patent/ATE392416T1/de active
- 2003-12-16 MX MXPA05006772A patent/MXPA05006772A/es active IP Right Grant
- 2003-12-16 JP JP2004561498A patent/JP4545000B2/ja not_active Expired - Fee Related
- 2003-12-16 SI SI200331217T patent/SI1578727T1/sl unknown
- 2003-12-16 CA CA2508923A patent/CA2508923C/en not_active Expired - Lifetime
- 2003-12-16 PT PT03808299T patent/PT1578727E/pt unknown
- 2003-12-16 RS YUP-2005/0458A patent/RS51196B/sr unknown
- 2003-12-16 AU AU2003303221A patent/AU2003303221B2/en not_active Ceased
- 2003-12-16 DK DK03808299T patent/DK1578727T3/da active
- 2003-12-16 WO PCT/EP2003/051024 patent/WO2004056779A2/en not_active Ceased
- 2003-12-16 ES ES03808299T patent/ES2304544T3/es not_active Expired - Lifetime
- 2003-12-16 PL PL376997A patent/PL376997A1/pl not_active Application Discontinuation
- 2003-12-16 BR BR0317514-6A patent/BR0317514A/pt not_active IP Right Cessation
- 2003-12-16 NZ NZ540577A patent/NZ540577A/en not_active IP Right Cessation
- 2003-12-16 EP EP03808299A patent/EP1578727B1/en not_active Expired - Lifetime
- 2003-12-16 UA UAA200505286A patent/UA80303C2/uk unknown
- 2003-12-16 RU RU2005122924/04A patent/RU2328487C2/ru not_active IP Right Cessation
- 2003-12-16 DE DE60320457T patent/DE60320457T2/de not_active Expired - Lifetime
- 2003-12-18 CL CL200302684A patent/CL43546B/es active
- 2003-12-19 AR ARP030104728A patent/AR042629A1/es unknown
-
2004
- 2004-01-05 PE PE2004000014A patent/PE20040799A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR042629A1 (es) | 2005-06-29 |
| JP4545000B2 (ja) | 2010-09-15 |
| PE20040799A1 (es) | 2004-12-02 |
| WO2004056779A3 (en) | 2004-08-12 |
| ES2304544T3 (es) | 2008-10-16 |
| RS51196B (sr) | 2010-12-31 |
| PL376997A1 (pl) | 2006-01-23 |
| SI1578727T1 (sl) | 2008-08-31 |
| RS20050458A (sr) | 2007-08-03 |
| DE60320457T2 (de) | 2009-06-04 |
| JP2006512346A (ja) | 2006-04-13 |
| RU2005122924A (ru) | 2006-01-27 |
| EP1578727B1 (en) | 2008-04-16 |
| MXPA05006772A (es) | 2005-09-08 |
| BR0317514A (pt) | 2005-11-16 |
| AU2003303221A1 (en) | 2004-07-14 |
| US7674909B2 (en) | 2010-03-09 |
| PT1578727E (pt) | 2008-05-23 |
| RU2328487C2 (ru) | 2008-07-10 |
| TW200418471A (en) | 2004-10-01 |
| TWI322012B (en) | 2010-03-21 |
| WO2004056779A2 (en) | 2004-07-08 |
| DE60320457D1 (de) | 2008-05-29 |
| EP1578727A2 (en) | 2005-09-28 |
| CA2508923C (en) | 2011-09-20 |
| DK1578727T3 (da) | 2008-08-04 |
| US20060167047A1 (en) | 2006-07-27 |
| UA80303C2 (en) | 2007-09-10 |
| NZ540577A (en) | 2006-12-22 |
| CA2508923A1 (en) | 2004-07-08 |
| AU2003303221B2 (en) | 2009-09-17 |
| ATE392416T1 (de) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL43546B (es) | Compuesto derivado de tetrahidroquinolina con actividad moduladora del receptor fsh; composicion farmaceutica que contiene al compuesto; y uso del compuesto en la preparacion de medicamentos para la regulacion de la fertilidad. | |
| AR012717A1 (es) | Trihidrato de la sal de magnesio de s-omeprazol, proceso para su preparacion, composicion farmaceutica, y uso de dicho trihidrato para la fabricacion de medicamentos. | |
| EE05183B1 (et) | Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon | |
| AR028317A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion | |
| DK1263720T3 (da) | Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme | |
| NO20015309L (no) | 1- (P-tienylbenzyl)-imidazoler som anginotensin-(1-7) reseptoragonister, fremgangsmåte for fremstilling og anvendelse avde samme og farmasöytiske preparater som inneholder nevnteforbindelser | |
| TW200605882A (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
| BRPI0009956B1 (pt) | Composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma | |
| BR0005011B1 (pt) | mecanismo de soltura rápida para uso com respirador, testeira para uso com um respirador e respirador. | |
| BR0009083B1 (pt) | derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida. | |
| NO20035763L (no) | Tetrahydrokinolinderivater, farmasøytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet. | |
| BRPI0312649A2 (pt) | compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos. | |
| AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
| DE59905572D1 (de) | Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
| BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
| CL2003002685A1 (es) | Compuesto derivado de tetrahidroquinolina, con sustituyentes r4 y r5, con actividad moduladora del receptor fsh; composicion farmaceutica que contiene al compuesto; y uso del compuesto en la preparacion de un medicamento util para la regulacion de la | |
| PT1237559E (pt) | Combinacoes farmaceuticas compreendendo um antagonista do receptor p2t e megalatrano | |
| BR9906373B1 (pt) | compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos. | |
| AR022970A1 (es) | Compuestos antagonistas de la lhrh con propiedades mejoradas de sulubilidad, procedimiento para prepararlos, las composiciones farmrceuticas que los contienen, su uso para la preparacinn de medicamentos, y procedimiento para preparar dichos medicamentos | |
| NO306113B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
| UY27458A1 (es) | Tetrahidroquinolinas | |
| UY25357A1 (es) | Nuevos pentasacáridos, procedimiento para su preparación y composiciones farmacéuticas que los contienen. | |
| AR024232A1 (es) | Bromhidrato de eletriptan monohidratado, composicion farmaceutica, su uso en la preparacion de medicamentos y procedimiento para su preparacion | |
| CL2004001421A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor. |